Pharsight has launched of Phoenix WinNonlin, its next generation software tool for pharmacokinetic and pharmacodynamic (PK/PD) modeling and noncompartmental analysis. Phoenix WinNonlin 6.0 is the cornerstone of Phoenix, Pharsight's new desktop software platform that is designed to advance model-based drug development by providing an integrated environment for data analysis, modeling and simulation.

The major features of Phoenix WinNonlin 6.0 include a new graphical user interface that makes creation and re-use of PK/PD analysis workflows seamless
and intuitive, powerful native graphics and improved data management tools. Phoenix WinNonlin will be backward-compatible with WinNonlin versions 4 and 5.
Phoenix WinNonlin will continue to operate with Pharsight’s enterprise PK/PD data management system, Pharsight Knowledgebase Server (PKS), and can
also be used independently of PKS. In addition to the release of Phoenix WinNonlin 6.0, newly released Phoenix Connect software integrates applications built on the Phoenix platform with commonly used third-party analysis and modeling tools such as S-PLUS,NONMEM and SAS, and enables data import/export with emerging industry standards such as CDISC.

“The release of Phoenix WinNonlin represents an important milestone in Pharsight’s vision for software to enable model-based drug development and its utility in translational science,” said Daniel Weiner, Ph.D., senior vice president and chief technology officer of Pharsight. “Phoenix WinNonlin version 6.0 merges the trusted algorithms from WinNonlin with new powerful data management tools and high-quality graphics to support comprehensive PK/PD analysis. The Phoenix platform has been developed to provide a collaborative environment for drug development scientists and to shorten the learning curve to more complex and impactful modeling, which ultimately supports more confident and efficient clinical development decisions.”